Trade

with

Epizyme Inc
(NASDAQ: EPZM)
AdChoices
27.59
+0.48
+1.77%
After Hours :
27.59
0.00
0.00%

Open

26.00

Previous Close

27.11

Volume (Avg)

136.10k (338.49k)

Day's Range

25.92-27.76

52Wk Range

18.10-42.00

Market Cap.

910.45M

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

33.58M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 68.48M

    • Net Income

    • -3.48M

    • Market Cap.

    • 910.45M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -20.76

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -12.08

    • Price/Sales

    • 12.38

    • Price/Book Value

    • 4.89

    • Price/Cash flow

    • -40.49

      • EBITDA

      • -2.42M

      • Return on Capital %

      • -7.01

      • Return on Equity %

      • -9.83

      • Return on Assets %

      • -7.01

      • Book Value/Share

      • 5.65

      • Shares Outstanding

      • 33.58M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 48.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -1.93

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -36.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -20.08

            • 39.38

            • Net Profit Margin

            • -20.76

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 9.87

              • 2.92

              • Quick Ratio

              • 9.76

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.26

              • 2.21

              • Book Value/Share

              • 5.65

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -55.87

                • 238.10

                • P/E Ratio 5-Year High

                • -98.76

                • 634.30

                • P/E Ratio 5-Year Low

                • -39.10

                • 124.82

                • Price/Sales Ratio

                • 11.59

                • 8.94

                • Price/Book Value

                • 4.58

                • 8.12

                • Price/Cash Flow Ratio

                • -40.49

                • 47.85

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -9.83

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -7.01

                    (-)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -9.83

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • 0.34

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -3.13M
                  Operating Margin
                  -4.57
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -40.49
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  120.87%

                  Mutual Fund Ownership

                  30.68%

                  Float

                  34.63%

                  5% / Insider Ownership

                  0.45%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    3,252,475

                  • 0.00

                  • 9.68

                  • PrimeCap Odyssey Aggressive Growth Fund

                  •  

                    963,062

                  • 0.54

                  • 2.89

                  • Fidelity Advisor® Biotechnology Fund

                  •  

                    647,371

                  • 0.00

                  • 1.93

                  • SPDR® S&P Biotech ETF

                  •  

                    593,246

                  • 0.60

                  • 1.77

                  • iShares Nasdaq Biotechnology

                  •  

                    448,933

                  • 3.08

                  • 1.34

                  • JPM Global Healthcare

                  •  

                    437,252

                  • 0.00

                  • 1.30

                  • Vanguard Total Stock Mkt Idx

                  •  

                    323,844

                  • 68.43

                  • 0.96

                  • Vanguard Small Cap Index

                  •  

                    292,531

                  • 44.93

                  • 0.87

                  • BlackRock Health Sciences Opps Port

                  •  

                    269,160

                  • -12.38

                  • 0.80

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • NEA Management Company, LLC

                  •  

                    5,162,640

                  • -19.83%

                  • 15.37

                  • Fidelity Management and Research Company

                  •  

                    3,899,931

                  • +4.00%

                  • 11.69

                  • Bay City Capital LLC

                  •  

                    2,825,396

                  • -11.97%

                  • 8.41

                  • Mpm Asset Management, LLC

                  •  

                    2,413,819

                  • 0.00%

                  • 7.23

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Speculative Growth

                  Style

                  -

                  Epizyme Inc is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

                  Key People

                  Dr. Robert J. Gould, PhD

                  CEO/Director/President/Treasurer/CFO

                  Dr. Robert A. Copeland, PhD

                  Chief Scientific Officer/Executive VP

                  Dr. Andrew R. Allen

                  Director

                  Dr. Beth C. Seidenberg,M.D.

                  Director

                  Richard F. Pops

                  Director

                  • Epizyme Inc

                  • 400 Technology Square

                  • Cambridge, MA 02139

                  • USA.Map

                  • Phone: +1 617 229-5872

                  • Fax: +1 617 349-0707

                  • epizyme.com

                  Incorporated

                  2007

                  Employees

                  74

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: